NCT03029988 2020-09-10
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Navidea Biopharmaceuticals
Phase 1 Terminated
Navidea Biopharmaceuticals
Cardinal Health 414, LLC
Navidea Biopharmaceuticals